{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:37:11Z","timestamp":1788482231942,"version":"build-2803163510"},"reference-count":193,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2023MH102"],"award-info":[{"award-number":["ZR2023MH102"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2023QH007"],"award-info":[{"award-number":["ZR2023QH007"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014761","name":"Natural Science Foundation of Qingdao","doi-asserted-by":"publisher","award":["23-2-1-135-zyyd-jch"],"award-info":[{"award-number":["23-2-1-135-zyyd-jch"]}],"id":[{"id":"10.13039\/501100014761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009812","name":"Chinese Society of Clinical Oncology","doi-asserted-by":"publisher","award":["Y-QL2019-0337"],"award-info":[{"award-number":["Y-QL2019-0337"]}],"id":[{"id":"10.13039\/501100009812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803058"],"award-info":[{"award-number":["81803058"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82400429"],"award-info":[{"award-number":["82400429"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Non-coding RNA Research"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ncrna.2025.02.005","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T19:55:31Z","timestamp":1740081331000},"page":"67-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["miR-135b: A key role in cancer biology and therapeutic targets"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4144-2564","authenticated-orcid":false,"given":"Yingchun","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangshuang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinying","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ncrna.2025.02.005_bib1","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1002\/jcp.27486","article-title":"An overview of microRNAs: biology, functions, therapeutics, and analysis methods","volume":"234","author":"Saliminejad","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ncrna.2025.02.005_bib2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.placenta.2023.10.004","article-title":"MiR-135b-5p targets ADAM12 to suppress invasion and accelerate trophoblast apoptosis in preeclampsia","volume":"143","author":"Sun","year":"2023","journal-title":"Placenta"},{"issue":"6","key":"10.1016\/j.ncrna.2025.02.005_bib3","first-page":"3551","article-title":"miR-135b levels in the peripheral blood serve as a marker associated with acute ischemic stroke","volume":"19","author":"Yang","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ncrna.2025.02.005_bib4","first-page":"129","article-title":"miRBase: the microRNA sequence database","volume":"342","author":"Griffiths-Jones","year":"2006","journal-title":"Methods Mol. Biol."},{"issue":"4","key":"10.1016\/j.ncrna.2025.02.005_bib5","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jaci.2017.08.034","article-title":"MicroRNA","volume":"141","author":"Lu","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"issue":"5","key":"10.1016\/j.ncrna.2025.02.005_bib6","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.3390\/ijms21051723","article-title":"Regulatory mechanism of MicroRNA expression in cancer","volume":"21","author":"Ali Syeda","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"13","key":"10.1016\/j.ncrna.2025.02.005_bib7","doi-asserted-by":"crossref","first-page":"7167","DOI":"10.3390\/ijms23137167","article-title":"MicroRNA-based diagnosis and therapy","volume":"23","author":"Ho","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ncrna.2025.02.005_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111528","article-title":"MicroRNA: a signature for cancer progression","volume":"138","author":"Hussen","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"19","key":"10.1016\/j.ncrna.2025.02.005_bib9","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.3390\/cancers15194723","article-title":"MicroRNA-34 family in cancers: role, mechanism, and therapeutic potential","volume":"15","author":"Fu","year":"2023","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.ncrna.2025.02.005_bib10","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S1470-2045(17)30621-6","article-title":"Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study","volume":"18","author":"van Zandwijk","year":"2017","journal-title":"Lancet Oncol."},{"issue":"8","key":"10.1016\/j.ncrna.2025.02.005_bib11","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2217\/epi-2016-0035","article-title":"Clinical development of TargomiRs, a miRNA mimic-based treatment for patients with recurrent thoracic cancer","volume":"8","author":"Reid","year":"2016","journal-title":"Epigenomics"},{"issue":"Suppl 1","key":"10.1016\/j.ncrna.2025.02.005_bib12","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.21037\/tlcr.2018.01.11","article-title":"Response to \"An innovative mesothelioma treatment based on mir-16 mimic loaded EGFR targeted minicells (TargomiRs)\"","volume":"7","author":"van Zandwijk","year":"2018","journal-title":"Transl. Lung Cancer Res."},{"issue":"1","key":"10.1016\/j.ncrna.2025.02.005_bib13","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/carcin\/bgz183","article-title":"miR-155 as a novel clinical target for hematological malignancies","volume":"41","author":"Witten","year":"2020","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.ncrna.2025.02.005_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/14728214.2022.2049233","article-title":"Emerging drugs for the treatment of cutaneous T-cell lymphoma","volume":"27","author":"Cheng","year":"2022","journal-title":"Expet Opin. Emerg. Drugs"},{"issue":"3","key":"10.1016\/j.ncrna.2025.02.005_bib15","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/bjh.15547","article-title":"Cobomarsen, an oligonucleotide inhibitor of miR-155, co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma","volume":"183","author":"Seto","year":"2018","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.ncrna.2025.02.005_bib16","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/jcp.27138","article-title":"MicroRNA-10b expression predicts long-term survival in patients with solid tumor","volume":"234","author":"Zhang","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"15","key":"10.1016\/j.ncrna.2025.02.005_bib17","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1080\/15384101.2021.1949840","article-title":"The emerging role of miR-10 family in gastric cancer","volume":"20","author":"Liu","year":"2021","journal-title":"Cell Cycle"},{"issue":"1","key":"10.1016\/j.ncrna.2025.02.005_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s43046-022-00120-9","article-title":"Significance of metastamiR-10b in breast cancer therapeutics","volume":"34","author":"Raval","year":"2022","journal-title":"J. Egypt. Natl. Cancer Inst."},{"key":"10.1016\/j.ncrna.2025.02.005_bib19","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3389\/fonc.2013.00268","article-title":"MicroRNA-135b and its circuitry networks as potential therapeutic targets in colon cancer","volume":"3","author":"Khatri","year":"2013","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ncrna.2025.02.005_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2024.155547","article-title":"MicroRNA-135b mainly functions as an oncogene during tumor progression","volume":"262","author":"Tolue Ghasaban","year":"2024","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.ncrna.2025.02.005_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118417","article-title":"Identification of stool miR-135b-5p as a non-invasive diagnostic biomarker in later tumor stage of colorectal cancer","volume":"260","author":"Li","year":"2020","journal-title":"Life Sci."},{"issue":"35","key":"10.1016\/j.ncrna.2025.02.005_bib22","doi-asserted-by":"crossref","first-page":"37241","DOI":"10.18632\/oncotarget.5925","article-title":"miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal","volume":"6","author":"Lulli","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ncrna.2025.02.005_bib23","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1186\/s12935-020-01645-6","article-title":"Extracellular vesicle-associated miR-135b and -135a regulate stemness in Group 4 medulloblastoma cells by targeting angiomotin-like 2","volume":"20","author":"Choi","year":"2020","journal-title":"Cancer Cell Int."},{"issue":"18","key":"10.1016\/j.ncrna.2025.02.005_bib24","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.3390\/ijms20184473","article-title":"Differentially expressed microRNAs in MIA PaCa-2 and PANC-1 pancreas ductal adenocarcinoma cell lines are involved in cancer stem cell regulation","volume":"20","author":"Shen","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ncrna.2025.02.005_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153774","article-title":"Quercetin improves atrial fibrillation through inhibiting TGF-beta\/Smads pathway via promoting MiR-135b expression","volume":"93","author":"Wang","year":"2021","journal-title":"Phytomedicine"},{"issue":"7","key":"10.1016\/j.ncrna.2025.02.005_bib26","first-page":"7767","article-title":"miR-135b-5p regulates human mesenchymal stem cell osteogenic differentiation by facilitating the Hippo signaling pathway","volume":"10","author":"Si","year":"2017","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"6","key":"10.1016\/j.ncrna.2025.02.005_bib27","doi-asserted-by":"crossref","first-page":"536","DOI":"10.7150\/ijms.23402","article-title":"miRNA-135b contributes to triple negative breast cancer molecular heterogeneity: different expression profile in basal-like versus non-Basal-like phenotypes","volume":"15","author":"Uva","year":"2018","journal-title":"Int. J. Med. Sci."},{"issue":"26","key":"10.1016\/j.ncrna.2025.02.005_bib28","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1182\/blood-2011-05-354654","article-title":"miR-135b mediates NPM-ALK-driven oncogenicity and renders IL-17-producing immunophenotype to anaplastic large cell lymphoma","volume":"118","author":"Matsuyama","year":"2011","journal-title":"Blood"},{"issue":"47","key":"10.1016\/j.ncrna.2025.02.005_bib29","doi-asserted-by":"crossref","first-page":"77978","DOI":"10.18632\/oncotarget.12866","article-title":"miR-135b-5p inhibits LPS-induced TNFalpha production via silencing AMPK phosphatase Ppm1e","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.ncrna.2025.02.005_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125412","article-title":"MicroRNA-135b regulates leucine zipper tumor suppressor 1 in cutaneous squamous cell carcinoma","volume":"10","author":"Olasz","year":"2015","journal-title":"PLoS One"},{"issue":"48","key":"10.1016\/j.ncrna.2025.02.005_bib31","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1038\/onc.2016.157","article-title":"miR-135b, a key regulator of malignancy, is linked to poor prognosis in human myxoid liposarcoma","volume":"35","author":"Nezu","year":"2016","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.ncrna.2025.02.005_bib32","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1158\/1078-0432.CCR-13-1750","article-title":"Identification of microRNA-135b in stool as a potential noninvasive biomarker for colorectal cancer and adenoma","volume":"20","author":"Wu","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.ncrna.2025.02.005_bib33","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s10266-024-00934-0","article-title":"The role of MicroRNAs in the diagnosis and treatment of oral premalignant disorders","volume":"112","author":"Fathima","year":"2024","journal-title":"Odontology"},{"issue":"2","key":"10.1016\/j.ncrna.2025.02.005_bib34","first-page":"589","article-title":"miR-135b-5p promotes gastric cancer progression by targeting CMTM3","volume":"52","author":"Lu","year":"2018","journal-title":"Int. J. Oncol."},{"issue":"4","key":"10.1016\/j.ncrna.2025.02.005_bib35","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s13105-020-00759-9","article-title":"Identification of miR-135b as a novel regulator of TGFbeta pathway in gastric cancer","volume":"76","author":"Bai","year":"2020","journal-title":"J. Physiol. Biochem."},{"issue":"8","key":"10.1016\/j.ncrna.2025.02.005_bib36","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.7150\/ijbs.58062","article-title":"MicroRNA-135b\/CAMK2D Axis contribute to malignant progression of gastric cancer through EMT process remodeling","volume":"17","author":"Huangfu","year":"2021","journal-title":"Int. J. Biol. Sci."},{"issue":"4","key":"10.1016\/j.ncrna.2025.02.005_bib37","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1053\/j.gastro.2018.11.059","article-title":"Interleukin 1 up-regulates MicroRNA 135b to promote inflammation-associated gastric carcinogenesis in mice","volume":"156","author":"Han","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ncrna.2025.02.005_bib38","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3389\/fonc.2020.00308","article-title":"Regulation of Integrin subunit alpha 2 by miR-135b-5p modulates chemoresistance in gastric cancer","volume":"10","author":"Wang","year":"2020","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.ncrna.2025.02.005_bib39","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1096\/fj.201800618RRR","article-title":"Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway","volume":"33","author":"Zhou","year":"2019","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.ncrna.2025.02.005_bib40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41420-022-00814-y","article-title":"MiR-135b-5p is an oncogene in pancreatic cancer to regulate GPRC5A expression by targeting transcription factor KLF4","volume":"8","author":"Liu","year":"2022","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.ncrna.2025.02.005_bib41","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41419-017-0233-y","article-title":"The MiR-135b-BMAL1-YY1 loop disturbs pancreatic clockwork to promote tumourigenesis and chemoresistance","volume":"9","author":"Jiang","year":"2018","journal-title":"Cell Death Dis."},{"issue":"12","key":"10.1016\/j.ncrna.2025.02.005_bib42","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1007\/s10620-017-4755-z","article-title":"miR-182 and miR-135b mediate the tumorigenesis and invasiveness of colorectal cancer cells via targeting ST6GALNAC2 and PI3K\/AKT pathway","volume":"62","author":"Jia","year":"2017","journal-title":"Dig. Dis. Sci."},{"issue":"4","key":"10.1016\/j.ncrna.2025.02.005_bib43","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1159\/000492284","article-title":"Knockdown of mir-135b sensitizes colorectal cancer cells to oxaliplatin-induced apoptosis through increase of FOXO1","volume":"48","author":"Qin","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"28","key":"10.1016\/j.ncrna.2025.02.005_bib44","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1038\/s41388-021-01898-z","article-title":"The HSF1\/miR-135b-5p axis induces protective autophagy to promote oxaliplatin resistance through the MUL1\/ULK1 pathway in colorectal cancer","volume":"40","author":"Wang","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.ncrna.2025.02.005_bib45","article-title":"Downregulation of miR-135b-5p suppresses progression of esophageal cancer and contributes to the effect of cisplatin","volume":"11","author":"Di","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.ncrna.2025.02.005_bib46","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13046-019-1024-3","article-title":"miR-135b-5p enhances doxorubicin-sensitivity of breast cancer cells through targeting anterior gradient 2","volume":"38","author":"Zhang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.ncrna.2025.02.005_bib47","first-page":"1514","article-title":"miR-135b-5p enhances the sensitivity of HER-2 positive breast cancer to trastuzumab via binding to cyclin D2","volume":"46","author":"Li","year":"2020","journal-title":"Int. J. Mol. Med."},{"issue":"9","key":"10.1016\/j.ncrna.2025.02.005_bib48","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/s41374-019-0258-1","article-title":"Repression of miR-135b-5p promotes metastasis of early-stage breast cancer by regulating downstream target SDCBP","volume":"99","author":"Pu","year":"2019","journal-title":"Lab. Invest."},{"issue":"5","key":"10.1016\/j.ncrna.2025.02.005_bib49","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41419-021-03773-x","article-title":"STAT3\/miR-135b\/NF-kappaB axis confers aggressiveness and unfavorable prognosis in non-small-cell lung cancer","volume":"12","author":"Zhao","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ncrna.2025.02.005_bib50","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1038\/ncomms2876","article-title":"MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1","volume":"4","author":"Lin","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ncrna.2025.02.005_bib51","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.omtn.2017.06.008","article-title":"miR-135b stimulates osteosarcoma recurrence and lung metastasis via Notch and wnt\/beta-catenin signaling","volume":"8","author":"Jin","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"3","key":"10.1016\/j.ncrna.2025.02.005_bib52","doi-asserted-by":"crossref","first-page":"569","DOI":"10.20892\/j.issn.2095-3941.2020.0033","article-title":"MiR-135a biogenesis and regulation in malignancy: a new hope for cancer research and therapy","volume":"17","author":"Cao","year":"2020","journal-title":"Cancer Biol Med"},{"issue":"10","key":"10.1016\/j.ncrna.2025.02.005_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2024.100997","article-title":"miR-135b: an emerging player in cardio-cerebrovascular diseases","volume":"14","author":"Shao","year":"2024","journal-title":"J Pharm Anal"},{"key":"10.1016\/j.ncrna.2025.02.005_bib54","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijcard.2018.07.016","article-title":"Overexpression of miR-135b attenuates pathological cardiac hypertrophy by targeting CACNA1C","volume":"269","author":"Chu","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ncrna.2025.02.005_bib55","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ijcard.2020.08.084","article-title":"MiR-135b might be a potential therapeutic target in the treatment of myocardial infarction","volume":"322","author":"Hu","year":"2021","journal-title":"Int. J. Cardiol."},{"issue":"5\u20136","key":"10.1016\/j.ncrna.2025.02.005_bib56","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000512949","article-title":"The clinical significance of miR-135b-5p and its role in the proliferation and apoptosis of Hippocampus neurons in children with temporal lobe epilepsy","volume":"42","author":"Li","year":"2020","journal-title":"Dev. Neurosci."},{"issue":"1","key":"10.1016\/j.ncrna.2025.02.005_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12263-024-00737-6","article-title":"Dysfunction of DMT1 and miR-135b in the gut-testis axis in high-fat diet male mice","volume":"19","author":"Zhang","year":"2024","journal-title":"Gene Nutr."},{"issue":"3","key":"10.1016\/j.ncrna.2025.02.005_bib58","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1080\/1061186X.2020.1833017","article-title":"MicroRNA-135b-5p promotes endothelial cell proliferation and angiogenesis in diabetic retinopathy mice by inhibiting Von Hipp-el-Lindau and elevating hypoxia inducible factor alpha expression","volume":"29","author":"Liu","year":"2021","journal-title":"J. Drug Target."},{"issue":"3","key":"10.1016\/j.ncrna.2025.02.005_bib59","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/08820139.2020.1841221","article-title":"MiR-135b alleviates airway inflammation in asthmatic children and experimental mice with asthma via regulating CXCL12","volume":"51","author":"Liu","year":"2022","journal-title":"Immunol. Investig."},{"issue":"4","key":"10.1016\/j.ncrna.2025.02.005_bib60","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.18632\/oncotarget.2965","article-title":"MicroRNA-135b, a HSF1 target, promotes tumor invasion and metastasis by regulating RECK and EVI5 in hepatocellular carcinoma","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.ncrna.2025.02.005_bib61","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s12263-015-0500-4","article-title":"Influence of miRNA-106b and miRNA-135a on butyrate-regulated expression of p21 and Cyclin D2 in human colon adenoma cells","volume":"10","author":"Schlormann","year":"2015","journal-title":"Gene Nutr."},{"issue":"10","key":"10.1016\/j.ncrna.2025.02.005_bib62","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317712443","article-title":"Morin inhibited lung cancer cells viability, growth, and migration by suppressing miR-135b and inducing its target CCNG2","volume":"39","author":"Yao","year":"2017","journal-title":"Tumour Biol"},{"issue":"12","key":"10.1016\/j.ncrna.2025.02.005_bib63","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3858\/emm.2012.44.12.079","article-title":"Estradiol regulates miR-135b and mismatch repair gene expressions via estrogen receptor-beta in colorectal cells","volume":"44","author":"He","year":"2012","journal-title":"Exp. Mol. Med."},{"issue":"3","key":"10.1016\/j.ncrna.2025.02.005_bib64","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s12029-021-00660-8","article-title":"The promising effect of peucedanum chenur chloroformic extract on prevention of human colorectal cancer progression by modulating miR-135b, miR-21, and APC genes","volume":"53","author":"Fadaei","year":"2022","journal-title":"J. Gastrointest. Cancer"},{"issue":"8","key":"10.1016\/j.ncrna.2025.02.005_bib65","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1158\/1940-6207.CAPR-17-0382","article-title":"KLF4 mediates the effect of 5-ASA on the beta-catenin pathway in colon cancer cells","volume":"11","author":"Parenti","year":"2018","journal-title":"Cancer Prev. Res."},{"issue":"9","key":"10.1016\/j.ncrna.2025.02.005_bib66","first-page":"856","article-title":"Down-regulation of miR-135b in colon adenocarcinoma induced by a TGF-beta receptor I kinase inhibitor (SD-208)","volume":"18","author":"Akbari","year":"2015","journal-title":"Iran J Basic Med Sci"},{"issue":"4","key":"10.1016\/j.ncrna.2025.02.005_bib67","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ccr.2014.03.006","article-title":"MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer","volume":"25","author":"Valeri","year":"2014","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.ncrna.2025.02.005_bib68","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12275-023-00100-1","article-title":"miR-135b aggravates fusobacterium nucleatum-induced cisplatin resistance in colorectal cancer by targeting KLF13","volume":"62","author":"Zeng","year":"2024","journal-title":"J. Microbiol."},{"key":"10.1016\/j.ncrna.2025.02.005_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118133","article-title":"High expression of miR-135b predicts malignant transformation and poor prognosis of gastric cancer","volume":"257","author":"Wu","year":"2020","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.ncrna.2025.02.005_bib70","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bbrc.2020.07.008","article-title":"MiR-135b promotes HCC tumorigenesis through a positive-feedback loop","volume":"530","author":"Xin","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.ncrna.2025.02.005_bib71","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.cellsig.2014.02.022","article-title":"Galpha12gep oncogene inhibits FOXO1 in hepatocellular carcinoma as a consequence of miR-135b and miR-194 dysregulation","volume":"26","author":"Jung","year":"2014","journal-title":"Cell. Signal."},{"issue":"8","key":"10.1016\/j.ncrna.2025.02.005_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109996","article-title":"Suppression of breast cancer progression by FBXL16 via oxygen-independent regulation of HIF1alpha stability","volume":"37","author":"Kim","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.ncrna.2025.02.005_bib73","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.canlet.2017.08.005","article-title":"A miR-135b-TAZ positive feedback loop promotes epithelial-mesenchymal transition (EMT) and tumorigenesis in osteosarcoma","volume":"407","author":"Shen","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ncrna.2025.02.005_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117478","article-title":"lncRNA PCAT18 inhibits proliferation, migration and invasion of gastric cancer cells through miR-135b suppression to promote CLDN11 expression","volume":"249","author":"Zhang","year":"2020","journal-title":"Life Sci."},{"issue":"7","key":"10.1016\/j.ncrna.2025.02.005_bib75","first-page":"1659","article-title":"The lncRNA UCA1 enhances pancreatic cancer EMT by regulating miR-708-5p and miR-135b-5p: a bioinformatics approach","volume":"53","author":"Askari","year":"2024","journal-title":"Iran. J. Public Health"},{"issue":"1","key":"10.1016\/j.ncrna.2025.02.005_bib76","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20181440","article-title":"LncRNA GAS8-AS1 suppresses papillary thyroid carcinoma cell growth through the miR-135b-5p\/CCND2 axis","volume":"39","author":"Chen","year":"2019","journal-title":"Biosci. Rep."},{"issue":"1","key":"10.1016\/j.ncrna.2025.02.005_bib77","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5603\/ep.97567","article-title":"p53-associated miRNAs repress lncRNA ZFAS1 to retard the proliferation of papillary thyroid carcinoma","volume":"75","author":"Wang","year":"2024","journal-title":"Endokrynol. Pol."},{"issue":"3","key":"10.1016\/j.ncrna.2025.02.005_bib78","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3892\/mmr.2021.12288","article-title":"Long non-coding RNA DANCR represses the viability, migration and invasion of multiple myeloma cells by sponging miR-135b-5p to target KLF9","volume":"24","author":"Wu","year":"2021","journal-title":"Mol. Med. Rep."},{"issue":"8","key":"10.1016\/j.ncrna.2025.02.005_bib79","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41419-024-07020-x","article-title":"LncRNA HAGLROS promotes breast cancer evolution through miR-135b-3p\/COL10A1 axis and exosome-mediated macrophage M2 polarization","volume":"15","author":"Meng","year":"2024","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.ncrna.2025.02.005_bib80","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41419-019-1479-3","article-title":"Lnc SMAD5-AS1 as ceRNA inhibit proliferation of diffuse large B cell lymphoma via Wnt\/beta-catenin pathway by sponging miR-135b-5p to elevate expression of APC","volume":"10","author":"Zhao","year":"2019","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.ncrna.2025.02.005_bib81","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3727\/096504017X14850182723737","article-title":"Long noncoding RNA GAS5 inhibits tumorigenesis and enhances radiosensitivity by suppressing miR-135b expression in non-small cell lung cancer","volume":"25","author":"Xue","year":"2017","journal-title":"Oncol. Res."},{"issue":"3","key":"10.1016\/j.ncrna.2025.02.005_bib82","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1055\/a-2184-8945","article-title":"LncRNA LINC01339 hinders the development of wilms' tumor via MiR-135b-3p\/ADH1C Axis","volume":"56","author":"Yu","year":"2024","journal-title":"Horm. Metab. Res."},{"issue":"1","key":"10.1016\/j.ncrna.2025.02.005_bib83","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12935-024-03433-y","article-title":"Adipocytes promote metastasis of breast cancer by attenuating the FOXO1 effects and regulating copper homeostasis","volume":"24","author":"Chen","year":"2024","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.ncrna.2025.02.005_bib84","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s12935-021-02015-6","article-title":"Circular RNA hsa_circ_0044234 as distinct molecular signature of triple negative breast cancer: a potential regulator of GATA3","volume":"21","author":"Darbeheshti","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"4","key":"10.1016\/j.ncrna.2025.02.005_bib85","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s10528-023-10331-x","article-title":"Evaluation of circ_0000977-mediated regulatory network in breast cancer: a potential discriminative biomarker for triple-negative tumors","volume":"61","author":"Darbeheshti","year":"2023","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.ncrna.2025.02.005_bib86","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.2147\/OTT.S242001","article-title":"CircNOL10 acts as a sponge of miR-135a\/b-5p in suppressing colorectal cancer progression via regulating KLF9","volume":"13","author":"Zhang","year":"2020","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.ncrna.2025.02.005_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215589","article-title":"YAP derived circ-LECRC functions as a \"brake signal\" to suppress hyperactivation of oncogenic YAP signalling in colorectal cancer","volume":"532","author":"An","year":"2022","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.ncrna.2025.02.005_bib88","doi-asserted-by":"crossref","first-page":"5259","DOI":"10.18632\/aging.102945","article-title":"Whole-transcriptome analysis reveals a potential hsa_circ_0001955\/hsa_circ_0000977-mediated miRNA-mRNA regulatory sub-network in colorectal cancer","volume":"12","author":"Ding","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"4","key":"10.1016\/j.ncrna.2025.02.005_bib89","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13651","article-title":"Circ_0000471 suppresses the progression of ovarian cancer through mediating mir-135b-5p\/dusp5 axis","volume":"89","author":"Yu","year":"2023","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.ncrna.2025.02.005_bib90","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.2147\/OTT.S207938","article-title":"Circular RNA CDR1as acts as a sponge of miR-135b-5p to suppress ovarian cancer progression","volume":"12","author":"Chen","year":"2019","journal-title":"OncoTargets Ther."},{"issue":"46","key":"10.1016\/j.ncrna.2025.02.005_bib91","first-page":"3269","article-title":"[Clinicopathological significance and function of miR-135b in the occurrence and development of gastric cancer]","volume":"92","author":"Wang","year":"2012","journal-title":"Zhonghua Yixue Zazhi"},{"key":"10.1016\/j.ncrna.2025.02.005_bib92","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fcimb.2017.00185","article-title":"Deregulation of MicroRNAs in gastric lymphomagenesis induced in the d3Tx mouse model of Helicobacter pylori infection","volume":"7","author":"Floch","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"6","key":"10.1016\/j.ncrna.2025.02.005_bib93","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.3748\/wjg.v22.i6.2060","article-title":"hsa-miR-29c and hsa-miR-135b differential expression as potential biomarker of gastric carcinogenesis","volume":"22","author":"Vidal","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.ncrna.2025.02.005_bib94","doi-asserted-by":"crossref","first-page":"33","DOI":"10.15430\/JCP.2017.22.1.33","article-title":"Differential MicroRNA expression between gastric cancer tissue and non-cancerous gastric mucosa according to Helicobacter pylori status","volume":"22","author":"Lee","year":"2017","journal-title":"J Cancer Prev"},{"issue":"9","key":"10.1016\/j.ncrna.2025.02.005_bib95","doi-asserted-by":"crossref","first-page":"797","DOI":"10.21037\/atm-21-1631","article-title":"Gastric cancer-associated microRNA expression signatures: integrated bioinformatics analysis, validation, and clinical significance","volume":"9","author":"Liu","year":"2021","journal-title":"Ann. Transl. Med."},{"issue":"1","key":"10.1016\/j.ncrna.2025.02.005_bib96","doi-asserted-by":"crossref","first-page":"167","DOI":"10.5114\/aoms.2019.87761","article-title":"MiR-135b-5p promotes viability, proliferation, migration and invasion of gastric cancer cells by targeting Kruppel-like factor 4 (KLF4)","volume":"16","author":"Chen","year":"2020","journal-title":"Arch. Med. Sci."},{"issue":"1","key":"10.1016\/j.ncrna.2025.02.005_bib97","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1186\/s12885-018-4980-7","article-title":"APC gene is modulated by hsa-miR-135b-5p in both diffuse and intestinal gastric cancer subtypes","volume":"18","author":"Magalhaes","year":"2018","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.ncrna.2025.02.005_bib98","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00262-021-02991-8","article-title":"Gastric cancer-derived exosomal miR-135b-5p impairs the function of Vgamma9Vdelta2 T cells by targeting specificity protein 1","volume":"71","author":"Li","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.ncrna.2025.02.005_bib99","article-title":"Genomic profiling and functional analysis of let-7c miRNA-mRNA interactions identify SOX13 to Be involved in invasion and progression of pancreatic cancer","volume":"2020","author":"Nelson","year":"2020","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ncrna.2025.02.005_bib100","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12935-020-01210-1","article-title":"Silencing of microRNA-135b inhibits invasion, migration, and stemness of CD24(+)CD44(+) pancreatic cancer stem cells through JADE-1-dependent AKT\/mTOR pathway","volume":"20","author":"Zhou","year":"2020","journal-title":"Cancer Cell Int."},{"issue":"37","key":"10.1016\/j.ncrna.2025.02.005_bib101","doi-asserted-by":"crossref","first-page":"62195","DOI":"10.18632\/oncotarget.19150","article-title":"Overexpression of miR-135b-5p promotes unfavorable clinical characteristics and poor prognosis via the repression of SFRP4 in pancreatic cancer","volume":"8","author":"Han","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ncrna.2025.02.005_bib102","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.biopha.2017.11.074","article-title":"miR-135b-5p Promotes migration, invasion and EMT of pancreatic cancer cells by targeting NR3C2","volume":"96","author":"Zhang","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.ncrna.2025.02.005_bib103","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3233\/CBM-181420","article-title":"An eight-miRNA signature expression-based risk scoring system for prediction of survival in pancreatic adenocarcinoma","volume":"23","author":"Dou","year":"2018","journal-title":"Cancer Biomarkers"},{"issue":"2","key":"10.1016\/j.ncrna.2025.02.005_bib104","doi-asserted-by":"crossref","first-page":"E86","DOI":"10.1002\/ijc.26466","article-title":"Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma","volume":"131","author":"Munding","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ncrna.2025.02.005_bib105","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2907554","article-title":"Downregulation of hsa-miR-135b-5p inhibits cell proliferation, migration, and invasion in colon adenocarcinoma","volume":"2022","author":"Zhang","year":"2022","journal-title":"Genet. Res."},{"issue":"1","key":"10.1016\/j.ncrna.2025.02.005_bib106","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/15384047.2021.2017222","article-title":"Cancer-associated fibroblasts derived extracellular vesicles promote angiogenesis of colorectal adenocarcinoma cells through miR-135b-5p\/FOXO1 axis","volume":"23","author":"Dai","year":"2022","journal-title":"Cancer Biol. Ther."},{"issue":"1","key":"10.1016\/j.ncrna.2025.02.005_bib107","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/ijc.29681","article-title":"miR-135b- and miR-146b-dependent silencing of calcium-sensing receptor expression in colorectal tumors","volume":"138","author":"Fetahu","year":"2016","journal-title":"Int. J. Cancer"},{"issue":"12","key":"10.1016\/j.ncrna.2025.02.005_bib108","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00109-012-0918-8","article-title":"Specific alterations of the microRNA transcriptome and global network structure in colorectal cancer after treatment with MAPK\/ERK inhibitors","volume":"90","author":"Ragusa","year":"2012","journal-title":"J. Mol. Med. (Berl.)"},{"issue":"4","key":"10.1016\/j.ncrna.2025.02.005_bib109","first-page":"199","article-title":"Circulating miR-17-3p, miR-29a, miR-92a and miR-135b in serum: evidence against their usage as biomarkers in colorectal cancer","volume":"12","author":"Faltejskova","year":"2012","journal-title":"Cancer Biomarkers"},{"issue":"8","key":"10.1016\/j.ncrna.2025.02.005_bib110","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10585-016-9810-1","article-title":"Prognostic value of 5-microRNA based signature in T2-T3N0 colon cancer","volume":"33","author":"Bobowicz","year":"2016","journal-title":"Clin. Exp. Metastasis"},{"issue":"1","key":"10.1016\/j.ncrna.2025.02.005_bib111","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1751-2980.2009.00413.x","article-title":"Initial study of microRNA expression profiles of colonic cancer without lymph node metastasis","volume":"11","author":"Wang","year":"2010","journal-title":"J Dig Dis"},{"issue":"5","key":"10.1016\/j.ncrna.2025.02.005_bib112","doi-asserted-by":"crossref","first-page":"6637","DOI":"10.1007\/s13277-015-4550-4","article-title":"MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations","volume":"37","author":"Ozcan","year":"2016","journal-title":"Tumour Biol"},{"issue":"9","key":"10.1016\/j.ncrna.2025.02.005_bib113","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.3390\/cancers14092109","article-title":"MicroRNA expression profiling predicts nodal status and disease recurrence in patients treated with curative intent for colorectal cancer","volume":"14","author":"Davey","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ncrna.2025.02.005_bib114","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1186\/s12885-017-3739-x","article-title":"microRNA-193a-3p is specifically down-regulated and acts as a tumor suppressor in BRAF-mutated colorectal cancer","volume":"17","author":"Takahashi","year":"2017","journal-title":"BMC Cancer"},{"issue":"18","key":"10.1016\/j.ncrna.2025.02.005_bib115","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1158\/1078-0432.CCR-12-0016","article-title":"The rectal cancer microRNAome--microRNA expression in rectal cancer and matched normal mucosa","volume":"18","author":"Gaedcke","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.ncrna.2025.02.005_bib116","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4132\/jptm.2022.02.19","article-title":"Expression of specific microRNAs in tissue and plasma in colorectal cancer","volume":"57","author":"Fellizar","year":"2023","journal-title":"J Pathol Transl Med"},{"key":"10.1016\/j.ncrna.2025.02.005_bib117","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijsu.2014.12.009","article-title":"MicroRNAs associated with initiation and progression of colonic polyp: a feasibility study","volume":"13","author":"Aslam","year":"2015","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.ncrna.2025.02.005_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinsp.2023.100271","article-title":"Effect of the MiR-99b and MiR-135b on peritoneal carcinomatosis and liver metastasis in colorectal cancer","volume":"78","author":"Aziret","year":"2023","journal-title":"Clinics"},{"issue":"1\u20132","key":"10.1016\/j.ncrna.2025.02.005_bib119","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11010-013-1916-z","article-title":"MicroRNA-135b regulates metastasis suppressor 1 expression and promotes migration and invasion in colorectal cancer","volume":"388","author":"Wu","year":"2014","journal-title":"Mol. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.ncrna.2025.02.005_bib120","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.3892\/or.2014.3694","article-title":"MicroRNA-135b regulates the stability of PTEN and promotes glycolysis by targeting USP13 in human colorectal cancers","volume":"33","author":"Xiang","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ncrna.2025.02.005_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.110029","article-title":"Cancer-associated fibroblasts-derived exosomes upregulate microRNA-135b-5p to promote colorectal cancer cell growth and angiogenesis by inhibiting thioredoxin-interacting protein","volume":"84","author":"Yin","year":"2021","journal-title":"Cell. Signal."},{"issue":"18","key":"10.1016\/j.ncrna.2025.02.005_bib122","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1097\/CM9.0000000000000427","article-title":"Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on the Cancer Genome Atlas (TCGA) and bioinformatics","volume":"132","author":"Li","year":"2019","journal-title":"Chin Med J (Engl)"},{"issue":"3","key":"10.1016\/j.ncrna.2025.02.005_bib123","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/SLA.0000000000003369","article-title":"Prognostic value of a four-miRNA signature in patients with lymph node positive locoregional esophageal squamous cell carcinoma undergoing complete surgical resection","volume":"273","author":"Wen","year":"2021","journal-title":"Ann. Surg."},{"issue":"4","key":"10.1016\/j.ncrna.2025.02.005_bib124","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.athoracsur.2012.04.145","article-title":"MicroRNA expression profiling of esophageal cancer before and after induction chemoradiotherapy","volume":"94","author":"Ko","year":"2012","journal-title":"Ann. Thorac. Surg."},{"issue":"5","key":"10.1016\/j.ncrna.2025.02.005_bib125","article-title":"A ten-microRNA signature identified from a genome-wide microRNA expression profiling in human epithelial ovarian cancer","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ncrna.2025.02.005_bib126","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s10735-022-10080-y","article-title":"MiR-135b improves proliferation and regulates chemotherapy resistance in ovarian cancer","volume":"53","author":"Wang","year":"2022","journal-title":"J. Mol. Histol."},{"issue":"3","key":"10.1016\/j.ncrna.2025.02.005_bib127","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ygyno.2014.09.010","article-title":"Dysregulated microRNA expression in adenocarcinoma of the uterine cervix: clinical impact of miR-363-3p","volume":"135","author":"Park","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ncrna.2025.02.005_bib128","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1002\/jcp.27160","article-title":"The potential prognostic and therapeutic application of tissue and circulating microRNAs in cervical cancer","volume":"234","author":"Hasanzadeh","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.ncrna.2025.02.005_bib129","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086061","article-title":"Genetic variants in microRNA target sites of 37 selected cancer-related genes and the risk of cervical cancer","volume":"9","author":"Mi","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.ncrna.2025.02.005_bib130","first-page":"10294","article-title":"Down-regulation of microRNA-135b inhibited growth of cervical cancer cells by targeting FOXO1","volume":"8","author":"Xu","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"5","key":"10.1016\/j.ncrna.2025.02.005_bib131","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.3892\/ijo.2016.3405","article-title":"miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2","volume":"48","author":"Hua","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"10","key":"10.1016\/j.ncrna.2025.02.005_bib132","doi-asserted-by":"crossref","first-page":"530","DOI":"10.5603\/GP.a2017.0097","article-title":"Dysregulation of microRNAs in triple-negative breast cancer","volume":"88","author":"Paszek","year":"2017","journal-title":"Ginekol. Pol."},{"issue":"6","key":"10.1016\/j.ncrna.2025.02.005_bib133","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/j.ajpath.2013.02.046","article-title":"miR-135b coordinates progression of ErbB2-driven mammary carcinomas through suppression of MID1 and MTCH2","volume":"182","author":"Arigoni","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"7","key":"10.1016\/j.ncrna.2025.02.005_bib134","doi-asserted-by":"crossref","first-page":"10819","DOI":"10.1002\/jcp.27906","article-title":"miR-135b promotes proliferation and metastasis by targeting APC in triple-negative breast cancer","volume":"234","author":"Lv","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"7","key":"10.1016\/j.ncrna.2025.02.005_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e28242","article-title":"Identification of cuproptosis-related miRNAs in triple-negative breast cancer and analysis of the miRNA-mRNA regulatory network","volume":"10","author":"Wang","year":"2024","journal-title":"Heliyon"},{"issue":"7","key":"10.1016\/j.ncrna.2025.02.005_bib136","doi-asserted-by":"crossref","first-page":"11768","DOI":"10.1002\/jcp.27839","article-title":"Identification of dysregulated miRNAs in triple negative breast cancer: a meta-analysis approach","volume":"234","author":"Naorem","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.ncrna.2025.02.005_bib137","doi-asserted-by":"crossref","first-page":"6553","DOI":"10.1038\/s41598-021-85746-w","article-title":"Triple negative aggressive phenotype controlled by miR-135b and miR-365: new theranostics candidates","volume":"11","author":"Bertoli","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ncrna.2025.02.005_bib138","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1186\/s12885-018-4631-z","article-title":"Differential expression of hsa-miR-221, hsa-miR-21, hsa-miR-135b, and hsa-miR-29c suggests a field effect in oral cancer","volume":"18","author":"Lopes","year":"2018","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.ncrna.2025.02.005_bib139","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/03009734.2018.1439551","article-title":"MicroRNA meta-signature of oral cancer: evidence from a meta-analysis","volume":"123","author":"Zeljic","year":"2018","journal-title":"Upsala J. Med. Sci."},{"issue":"4","key":"10.1016\/j.ncrna.2025.02.005_bib140","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1111\/odi.14185","article-title":"Meta-signature guided investigation of miRNA candidates as potential biomarkers of oral cancer","volume":"29","author":"Stojkovic","year":"2023","journal-title":"Oral Dis."},{"key":"10.1016\/j.ncrna.2025.02.005_bib141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.oraloncology.2017.07.026","article-title":"Complex integrated analysis of lncRNAs-miRNAs-mRNAs in oral squamous cell carcinoma","volume":"73","author":"Li","year":"2017","journal-title":"Oral Oncol."},{"issue":"4","key":"10.1016\/j.ncrna.2025.02.005_bib142","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1177\/039463201002300427","article-title":"MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression","volume":"23","author":"Scapoli","year":"2010","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"18","key":"10.1016\/j.ncrna.2025.02.005_bib143","doi-asserted-by":"crossref","first-page":"7575","DOI":"10.7314\/APJCP.2014.15.18.7575","article-title":"Five miRNAs as novel diagnostic biomarker candidates for primary nasopharyngeal carcinoma","volume":"15","author":"Tang","year":"2014","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"issue":"6","key":"10.1016\/j.ncrna.2025.02.005_bib144","first-page":"5803","article-title":"Screening of key miRNAs and evaluation of their diagnostic and prognostic values in nasopharyngeal carcinoma","volume":"17","author":"Zhuo","year":"2019","journal-title":"Oncol. Lett."},{"issue":"6","key":"10.1016\/j.ncrna.2025.02.005_bib145","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s12033-022-00457-5","article-title":"miR-135b-5p targets SIRT1 to inhibit deacetylation of c-JUN and increase MMP7 expression to promote migration and invasion of nasopharyngeal carcinoma cells","volume":"64","author":"Cheng","year":"2022","journal-title":"Mol. Biotechnol."},{"issue":"32","key":"10.1016\/j.ncrna.2025.02.005_bib146","article-title":"Identification of novel biomarkers and small-molecule compounds for nasopharyngeal carcinoma with metastasis","volume":"99","author":"Mi","year":"2020","journal-title":"Medicine (Baltim.)"},{"issue":"10387","key":"10.1016\/j.ncrna.2025.02.005_bib147","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(23)00020-X","article-title":"Thyroid cancer","volume":"401","author":"Chen","year":"2023","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ncrna.2025.02.005_bib148","first-page":"2144","article-title":"Micro-RNAs signatures in papillary thyroid carcinoma","volume":"25","author":"Mastronikolis","year":"2020","journal-title":"J BUON"},{"key":"10.1016\/j.ncrna.2025.02.005_bib149","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.semcancer.2021.03.027","article-title":"Epigenetic regulation of papillary thyroid carcinoma by long non-coding RNAs","volume":"83","author":"Lin","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ncrna.2025.02.005_bib150","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2147\/OTT.S43014","article-title":"Association between the expression of four upregulated miRNAs and extrathyroidal invasion in papillary thyroid carcinoma","volume":"6","author":"Wang","year":"2013","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.ncrna.2025.02.005_bib151","article-title":"GAS5 regulates RECK expression and inhibits invasion potential of HCC cells by sponging miR-135b","volume":"2019","author":"Yang","year":"2019","journal-title":"BioMed Res. Int."},{"issue":"10","key":"10.1016\/j.ncrna.2025.02.005_bib152","first-page":"1316","article-title":"[miR-135b promotes the invasion and metastasis of hepatocellular carcinoma cells]","volume":"31","author":"Zhang","year":"2015","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"key":"10.1016\/j.ncrna.2025.02.005_bib153","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/6517963","article-title":"Whole-Transcriptome sequencing combined with high-dimensional proteomic technologies reveals the potential value of miR-135b-5p as a biomarker for hepatocellular carcinoma","volume":"2023","author":"Zhang","year":"2023","journal-title":"BioMed Res. Int."},{"issue":"20","key":"10.1016\/j.ncrna.2025.02.005_bib154","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.3390\/cancers15205048","article-title":"Astragaloside IV attenuates programmed death-ligand 1-mediated immunosuppression during liver cancer development via the miR-135b-5p\/CNDP1 Axis","volume":"15","author":"Ma","year":"2023","journal-title":"Cancers"},{"issue":"15","key":"10.1016\/j.ncrna.2025.02.005_bib155","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1093\/hmg\/ddae068","article-title":"Highly homologous miR-135a and miR-135b converting non-small cell lung cancer from suppression to progression via enhancer switching","volume":"33","author":"Zhou","year":"2024","journal-title":"Hum. Mol. Genet."},{"issue":"32","key":"10.1016\/j.ncrna.2025.02.005_bib156","doi-asserted-by":"crossref","first-page":"51515","DOI":"10.18632\/oncotarget.9862","article-title":"YKT6 expression, exosome release, and survival in non-small cell lung cancer","volume":"7","author":"Ruiz-Martinez","year":"2016","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.ncrna.2025.02.005_bib157","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/s41416-024-02831-3","article-title":"Circulating miRNA panels as a novel non-invasive diagnostic, prognostic, and potential predictive biomarkers in non-small cell lung cancer (NSCLC)","volume":"131","author":"Abdipourbozorgbaghi","year":"2024","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.ncrna.2025.02.005_bib158","first-page":"7931","article-title":"Peripheral lung adenocarcinomas harboring epithelial growth factor receptor mutations with microRNA-135b overexpression are more likely to invade visceral pleura","volume":"14","author":"Le","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ncrna.2025.02.005_bib159","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.2147\/OTT.S240399","article-title":"CircLARP4 suppresses cell proliferation, invasion and glycolysis and promotes apoptosis in non-small cell lung cancer by targeting miR-135b","volume":"13","author":"Lu","year":"2020","journal-title":"OncoTargets Ther."},{"issue":"2","key":"10.1016\/j.ncrna.2025.02.005_bib160","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12813","article-title":"Melatonin may suppress lung adenocarcinoma progression via regulation of the circular noncoding RNA hsa_circ_0017109\/miR-135b-3p\/TOX3 axis","volume":"73","author":"Wang","year":"2022","journal-title":"J. Pineal Res."},{"issue":"12","key":"10.1016\/j.ncrna.2025.02.005_bib161","first-page":"800","article-title":"[Effect of circular RNA UBAP2 silencing on proliferation and invasion of human lung cancer A549 cells and its mechanism]","volume":"20","author":"Yin","year":"2017","journal-title":"Zhongguo Fei Ai Za Zhi"},{"issue":"2","key":"10.1016\/j.ncrna.2025.02.005_bib162","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.3892\/mmr.2015.3708","article-title":"MicroRNA-135b exerts oncogenic activity in glioblastoma via the inhibition of glycerol kinase 5 expression","volume":"12","author":"Yu","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"9","key":"10.1016\/j.ncrna.2025.02.005_bib163","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108810","article-title":"miR-135b contributes to the radioresistance by targeting GSK3beta in human glioblastoma multiforme cells","volume":"9","author":"Xiao","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ncrna.2025.02.005_bib164","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/CMR.0000000000000524","article-title":"MiR-135b is a novel oncogenic factor in cutaneous melanoma by targeting LATS2","volume":"29","author":"Hu","year":"2019","journal-title":"Melanoma Res."},{"issue":"3","key":"10.1016\/j.ncrna.2025.02.005_bib165","first-page":"689","article-title":"Effect of miR-135b inhibitor on biological characteristics of osteosarcoma cells through up-regulating PPM1A","volume":"12","author":"Gao","year":"2019","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"1\u20132","key":"10.1016\/j.ncrna.2025.02.005_bib166","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11010-014-2281-2","article-title":"MiR-135b promotes proliferation and invasion of osteosarcoma cells via targeting FOXO1","volume":"400","author":"Pei","year":"2015","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ncrna.2025.02.005_bib167","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/732690","article-title":"Identification of differentially expressed MicroRNAs in osteosarcoma","volume":"2011","author":"Lulla","year":"2011","journal-title":"Sarcoma"},{"issue":"16","key":"10.1016\/j.ncrna.2025.02.005_bib168","doi-asserted-by":"crossref","first-page":"26424","DOI":"10.18632\/oncotarget.15477","article-title":"microRNA-135b expression silences Ppm1e to provoke AMPK activation and inhibit osteoblastoma cell proliferation","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.ncrna.2025.02.005_bib169","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.3892\/ijo.2014.2641","article-title":"MicroRNA-135b promotes proliferation, invasion and migration of osteosarcoma cells by degrading myocardin","volume":"45","author":"Xu","year":"2014","journal-title":"Int. J. Oncol."},{"issue":"15","key":"10.1016\/j.ncrna.2025.02.005_bib170","doi-asserted-by":"crossref","first-page":"19589","DOI":"10.18632\/oncotarget.7319","article-title":"Serum high expression of miR-214 and miR-135b as novel predictor for myeloma bone disease development and prognosis","volume":"7","author":"Hao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ncrna.2025.02.005_bib171","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155495","article-title":"Promoting effects of MiR-135b on human multiple myeloma cells via regulation of the Wnt\/beta-catenin\/Versican signaling pathway","volume":"142","author":"Chen","year":"2021","journal-title":"Cytokine"},{"issue":"11","key":"10.1016\/j.ncrna.2025.02.005_bib172","article-title":"Upregulation of miR-135b is involved in the impaired osteogenic differentiation of mesenchymal stem cells derived from multiple myeloma patients","volume":"8","author":"Xu","year":"2013","journal-title":"PLoS One"},{"issue":"25","key":"10.1016\/j.ncrna.2025.02.005_bib173","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1182\/blood-2014-05-576116","article-title":"Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1","volume":"124","author":"Umezu","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ncrna.2025.02.005_bib174","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3892\/ol.2015.3970","article-title":"miR-135b inhibits tumour metastasis in prostate cancer by targeting STAT6","volume":"11","author":"Wang","year":"2016","journal-title":"Oncol. Lett."},{"issue":"7","key":"10.1016\/j.ncrna.2025.02.005_bib175","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.molonc.2015.03.001","article-title":"MicroRNA-135b regulates ERalpha, AR and HIF1AN and affects breast and prostate cancer cell growth","volume":"9","author":"Aakula","year":"2015","journal-title":"Mol. Oncol."},{"issue":"5","key":"10.1016\/j.ncrna.2025.02.005_bib176","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1158\/0008-5472.CAN-10-2421","article-title":"Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells","volume":"71","author":"Ostling","year":"2011","journal-title":"Cancer Res."},{"issue":"24","key":"10.1016\/j.ncrna.2025.02.005_bib177","doi-asserted-by":"crossref","first-page":"6202","DOI":"10.3390\/cancers13246202","article-title":"Loss of microRNA-135b enhances bone metastasis in prostate cancer and predicts aggressiveness in human prostate samples","volume":"13","author":"Olivan","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ncrna.2025.02.005_bib178","article-title":"LncRNA GAPLINC promotes renal cell cancer tumorigenesis by targeting the miR-135b-5p\/CSF1 Axis","volume":"11","author":"Wang","year":"2021","journal-title":"Front. Oncol."},{"issue":"1\u20132","key":"10.1016\/j.ncrna.2025.02.005_bib179","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1023\/A:1013125027697","article-title":"Tumor physiology and drug resistance","volume":"20","author":"Tannock","year":"2001","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.ncrna.2025.02.005_bib180","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2021.100796","article-title":"Anticancer drug resistance: an update and perspective","volume":"59","author":"Nussinov","year":"2021","journal-title":"Drug Resist. Updates"},{"issue":"9","key":"10.1016\/j.ncrna.2025.02.005_bib181","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.3390\/ijms21093233","article-title":"Mechanisms of multidrug resistance in cancer chemotherapy","volume":"21","author":"Bukowski","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"10.1016\/j.ncrna.2025.02.005_bib182","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2209435120","article-title":"The moonlighting function of glycolytic enzyme enolase-1 promotes choline phospholipid metabolism and tumor cell proliferation","volume":"120","author":"Ma","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.ncrna.2025.02.005_bib183","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1096\/fj.201701456RR","article-title":"Helicobacter pylori-induced miR-135b-5p promotes cisplatin resistance in gastric cancer","volume":"33","author":"Shao","year":"2019","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.ncrna.2025.02.005_bib184","first-page":"1382","article-title":"MicroRNA-135b regulates apoptosis and chemoresistance in colorectal cancer by targeting large tumor suppressor kinase 2","volume":"5","author":"He","year":"2015","journal-title":"Am. J. Cancer Res."},{"issue":"12","key":"10.1016\/j.ncrna.2025.02.005_bib185","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1002\/mc.22710","article-title":"Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K\/AKT pathway","volume":"56","author":"Liu","year":"2017","journal-title":"Mol. Carcinog."},{"issue":"1","key":"10.1016\/j.ncrna.2025.02.005_bib186","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41389-021-00376-1","article-title":"Anti-miR-135\/SPOCK1 axis antagonizes the influence of metabolism on drug response in intestinal\/colon tumour organoids","volume":"11","author":"Babaei-Jadidi","year":"2022","journal-title":"Oncogenesis"},{"key":"10.1016\/j.ncrna.2025.02.005_bib187","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.biopha.2016.09.027","article-title":"miR-135b reverses chemoresistance of non-small cell lung cancer cells by downregulation of FZD1","volume":"84","author":"Su","year":"2016","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.ncrna.2025.02.005_bib188","first-page":"1309","article-title":"MiR-135b-5p inhibits the progression of malignant melanoma cells by targeting RBX1","volume":"24","author":"Zhang","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"5","key":"10.1016\/j.ncrna.2025.02.005_bib189","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.3390\/ijms22052464","article-title":"An integrated bioinformatics study of a novel niclosamide derivative, NSC765689, a potential GSK3beta\/beta-catenin\/STAT3\/CD44 suppressor with anti-glioblastoma properties","volume":"22","author":"Mokgautsi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ncrna.2025.02.005_bib190","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadva.2023.100078","article-title":"Identification of key microRNAs regulating ELOVL6 and glioblastoma tumorigenesis","volume":"3","author":"Istiqamah","year":"2023","journal-title":"BBA Adv"},{"key":"10.1016\/j.ncrna.2025.02.005_bib191","doi-asserted-by":"crossref","first-page":"9991","DOI":"10.2147\/OTT.S268214","article-title":"miR-135b-5p suppresses androgen receptor-enhanced hepatocellular carcinoma cell proliferation via regulating the HIF-2alpha\/c-Myc\/P27 signals in vitro","volume":"13","author":"Bao","year":"2020","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.ncrna.2025.02.005_bib192","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117672","article-title":"Urinary-derived extracellular vesicle microRNAs as non-invasive diagnostic biomarkers for early-stage renal cell carcinoma","volume":"552","author":"Zhang","year":"2024","journal-title":"Clin. Chim. Acta"},{"issue":"5","key":"10.1016\/j.ncrna.2025.02.005_bib193","first-page":"1635","article-title":"Role of miR-34 in gastric cancer: from bench to bedside","volume":"42","author":"Xiong","year":"2019","journal-title":"Oncol. Rep."}],"container-title":["Non-coding RNA Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468054025000277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468054025000277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T18:53:09Z","timestamp":1762627989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468054025000277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":193,"alternative-id":["S2468054025000277"],"URL":"https:\/\/doi.org\/10.1016\/j.ncrna.2025.02.005","relation":{},"ISSN":["2468-0540"],"issn-type":[{"value":"2468-0540","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"miR-135b: A key role in cancer biology and therapeutic targets","name":"articletitle","label":"Article Title"},{"value":"Non-coding RNA Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncrna.2025.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}